Quarterly Journal 47-3 Volume 47, Issue 3 November 2019

Please sign in to view the articles. Once you've signed in please refresh the page to see the download link. 

The AIPLA Quarterly Journal, a publication of the American Intellectual Property Law Association, is housed at the George Washington University Law School and is edited and managed by an Editorial Board of intellectual property experts and a staff of law students under the direction of the Editor-in-Chief, Professor Joan Schaffner.

The Quarterly Journal is dedicated to presenting materials relating to intellectual property matters and is published four times per year. Editorial Board members (all of whom are lawyers) are selected based upon demonstrated interest and experience, and student staff members are selected from the students of the GWU Law School.

QJ-1-100 QJ 47.3 - Patent Eligibility of Inventions Directed to Graphical User Interfaces

Malgorzata Kulczycka

Patent Eligibility of Inventions Directed to Graphical User Interfaces

The 2019 Guidance provides some clarity for determining patent eligible subject matter under § 101. For example, it clarifies that to be patent eligible, a claim needs to state a new and practical application of an alleged abstract idea.

As the USPTO continues to apply the 2019 Revised Guidance, the number of rejections under § 101 issued in patent applications directed to graphical user interfaces should continue to decline.

This article discusses several recent patent cases in which the inventions were directed to graphical user interfaces. In each of those cases, an applicant would have had a chance to advance their arguments against the § 101 rejections by showing how the recited graphical user interface integrates the alleged abstract idea into a practical application.

QJ-2-100 QJ 47.3 - The “Unwilling Licensee” in the Context of Standards Essential Patent Licensing Negotiations

Andre Schevciw

The “Unwilling Licensee” in the Context of Standards Essential Patent Licensing Negotiations

This article proposes a framework to determine whether an implementer of standards-essential patents (“SEPs”) is an “unwilling licensee” of fair, reasonable, and non-discriminatory (“FRAND”) licensing terms.

In recent years, scholars and courts have discussed extensively the potential for SEP holders to engage in “patent hold-up.” As a result, SEP holders are now mostly blocked from seeking injunctions, with a possible exception when the SEP implementer is an “unwilling licensee” of FRAND terms.

The SEP holder’s difficulty in seeking an injunction, the uncertainty in determining FRAND rates, and a lack of an agreed definition for “unwilling licensee” create the risk for the so-called “patent hold-out” problem. This article focuses on the “unwilling licensee” determination problem and proposes a framework based on a step-by-step, objective fact-based analysis. The framework aims to increase predictability for both SEP holders and SEP implementers.

QJ-3-100 QJ 47.3 - Artificial Human Life: Patentable, Playing God, Both?

Austin Grossfeld

Artificial Human Life: Patentable, Playing God, Both?

We as a species have been trying to learn how and why we do the things we do for hundreds of years. This curiosity resulted in scientists at the University of Cambridge making a revolutionary breakthrough by artificially creating an embryo in a laboratory setting.

However, with great discoveries come many questions. One of these questions is whether or not these scientists can patent their work. Attaining the answer to this question requires the analysis of decades of judicial, legislative, and agency decision-making.

This Note looks at the history of all three of these branches that factor into patent rights and requirements, while trying to narrow down the applicable precedent.

QJ-4-100 QJ 47.3 - Music to My Ears: Adding a Fair Use-Like Provision to the Anti-Bootlegging Statutes

Sean Hanlon

Music to My Ears: Adding a Fair Use-Like Provision to the Anti-Bootlegging Statutes

The federal anti-bootlegging statutes protect live musical performances from unauthorized use. The statutes were conceived in good faith, but have flaws and ambiguities that may impede their effectiveness. The main issues with the statutes are their conflicts with the First Amendment and Commerce Clause. While the statutes have survived challenges regarding the Commerce Clause, they remain vulnerable to First Amendment scrutiny because they lack a fair use exception.

This note delves into the existence and possible resolutions to these problems using social media and modern recording technology as possible bootlegging tools. It is imperative to make these changes as soon as possible considering the Beijing Audiovisual Treaty may further expand the copyright landscape to protect more forms of audiovisual works.

This Note suggests that the federal anti-bootlegging statutes be amended to add a fair use-like exception that may balance performers' rights with users' rights. In reaching this conclusion, this Note describes the digitization of recording technology, provides a comprehensive look into the anti-bootlegging statutes and their legislative history, and discusses copyright and anti-bootlegging cases addressing fair use and the First Amendment. Finally, this Note provides an example of how the anti-bootlegging statutes can be amended to prevent future problems.   

QJ-5-1 QJ 47.3 - Product Hopping Analysis: A More Beneficial Approach

Divesh Patel

Product Hopping Analysis: A More Beneficial Approach

Product hopping in the pharmaceutical industry has become more prevalent over recent years, and courts have had varying responses to address this behavior. By focusing on a traditional antitrust analysis for the pharmaceutical industry, which is not a well-functioning market, courts have reached inconsistent decisions that do not necessarily punish the market exploiter and reward the honest competitor.

This Note looks to the drug approval process in the European Union, specifically Germany, and proposes a new standard that focuses on additional clinical benefits. Although courts do not typically assess the value of parties’ innovations, the pharmaceutical field is unique in its relationship between competitors and consumer, and thus warrants a new approach to address these issues.

By focusing on the clinical benefits of new formulations, courts can better encourage valuable innovation by branded drug companies and protect the market from trivial advancements made solely for the purpose of excluding generic companies from the market.

Knobbe Martens

Upcoming Events

  • AIPLA CLE Webinar: The Fine Line Between Battling Online Infringers & Engaging in IP Trolling

    May 29, 2024 12:30 PM to 2:00 PM   |   Up to 90 CLE Minutes

    In their never-ending battle against Chinese and other international online infringers, some rightsowners have adopted an aggressive enforcement scheme that relies on sealed filings and ex parte TROs. Due to the fact that proceedings occur partially out of public purview, this enforcement scheme has been underdiscussed and has not received much critical scrutiny. This program will explain how the scheme works, document its prevalence, and show why it's likely an illegitimate enforcement practice.
  • AIPLA CLE Webinar: USPTO AI Guidelines

    June 20, 2024 12:30 PM to 2:00 PM   |   Up to 90 CLE Minutes

    Join us as our speakers discuss the recently issued USPTO examination guidance regarding patentability for artificial intelligence (AI)-assisted inventions. The guidance states that AI-assisted inventions are not “category unpatentable.” Instead, when a natural person provides a “significant contribution” to an invention, such an invention can be patentable even if an AI system contributed to the invention. While the guidance does not constitute law, it is grounded in law, i.e., the Federal Circuit’s so-called Pannu factors, which serve as a test for ensuring that a natural person contributed, at least in part, to the conception of the invention as required in the Federal Circuit’s Thaler decision on AI inventorship. The guidance also provides several useful guidelines and examples to help patent practitioners determine what constitutes a “significant contribution” for purposes of establishing natural person inventorship and, thus, patentability for AI-assisted inventions.
  • 2024 Trademark Boot Camp (TMBC)

    June 24 to 27, 2024

    The Fourteenth Annual Trademark Boot Camp is a comprehensive online CLE program designed for new practitioners and others interested in learning the basics of trademark practice. Topics include; trademark clearance, pre-filing considerations, trademark prosecution, international trademark filing strategies, disputes, including trademark investigations, cease-and-desist campaigns, Trademark Trial and Appeal Board (TTAB) practice, and an introduction to trademark litigation.
  • AIPLA 2024 Annual Meeting

    October 24 to 26, 2024

    Join us as we bring IP professionals together to learn and connect. More information coming soon! The 2024 Annual meeting will take place at the Gaylord National Harbor Resort. Leadership Meetings on Wednesday, October 23. Programming scheduled October 24-26.
  • omni-rancho-las-palmas-plaza-night-hero-2880x1870 2025 Leadership Institute

    January 29 to 30, 2025

    The Leadership Journey - From Survival (Subsistence) to Self-Fulfillment (Abundance). This invitation-only two-day program will address building strong leadership skills for all levels of experience. More details coming soon.